ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data
Saturday, May 3, 2014
Submitted by
Source
Source Name: The Lancet
This systematic review and meta-analysis of individual patient data from 15 RCTs (2385 pts) assessed the utility of preoperative chemotherapy in patients with primarily stages Ib-IIIa NSCLC. Chemotherapy resulted in a 13% reduction in death (HR 0.87, p=0.007), and a 5% survival improvement at 5 years. Improvement was also evident for recurrence free survival and time to distant recurrence. There was no evidence for a difference in effects based on chemo regimens or patient characteristics.
Printer-friendly
